the process for the diagnosis , early detection and prognosis of the clinical development of autosomal - dominant polycystic kidney disease comprises the step of determining the presence or absence or amplitude of at least three polypeptide markers in a urine sample , the polypeptide markers being selected from the markers characterized in table 1 by values for the molecular masses and migration times .